findmyKOL
Clinical trialNCT00731211CompletedPhase 2Interventional

Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma

SponsorSCRI Development Innovations, LLCEnrollment57Renal Cell Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • San Francisco Oncology Associates

    San Francisco, California, United States

  • Florida Cancer Specialists

    Fort Myers, Florida, United States

  • Watson Clinic Center for Cancer Care and Research

    Lakeland, Florida, United States

  • Florida Hospital Cancer Institute

    Orlando, Florida, United States

  • Gulfcoast Oncology Associates

    St. Petersburg, Florida, United States

  • Medical Oncology Associates of Augusta

    Augusta, Georgia, United States

  • Northeast Georgia Medical Center

    Gainesville, Georgia, United States

  • Baptist Hospital East

    Louisville, Kentucky, United States

  • Central Maine Medical Center

    Lewiston, Maine, United States

  • Grand Rapids Clinical Oncology Program

    Grand Rapids, Michigan, United States

  • St. Louis Cancer Care

    Chesterfield, Missouri, United States

  • University of Nebraska Medical Center

    Omaha, Nebraska, United States

  • Oncology Hematology Care

    Cincinnati, Ohio, United States

  • South Carolina Oncology Associates, Pa

    Columbia, South Carolina, United States

  • Chattanooga Oncology Hematology Associates

    Chattanooga, Tennessee, United States

  • Tennessee Oncology, Pllc

    Nashville, Tennessee, United States

  • Virginia Cancer Institute

    Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2008
Primary completion
31 May 2011
Completion
30 Sept 2012
Last update posted
20 May 2015
Registered enrollment
57
Registry id
NCT00731211

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.